Responses
Clinical/translational cancer immunotherapy
Original research
Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.